Developing a new antibody treatment for Duchenne's muscular dystrophy.
DEVELOPMENT OF ENZYME-LINKED IMMUNOSORBENT ASSAYS (ELISAS) FOR NINDS NIH BLUEPRINT NEUROTHERAPEUTICS (BPN) BIOLOGICS PROJECT
This study is working on a new antibody that could help treat Duchenne's muscular dystrophy (DMD), and it's testing how well it works and if it's safe in animal models before moving on to trials with people.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Battelle Centers/pub Hlth Res & Evaluatn NIH-funded |
| Lab location | 1 site (Columbus, United States) |
| Project ID | NIH-10948209 on NIH RePORTER |
What this research studies
This research focuses on creating and optimizing an antibody specifically designed to treat Duchenne's muscular dystrophy (DMD). The project involves evaluating the effectiveness of this antibody in animal models and completing necessary pre-clinical studies to ensure its safety and efficacy. If successful, this antibody could progress to clinical trials, potentially offering a new treatment option for patients with DMD. The research is part of a larger initiative to advance neurotherapeutics through innovative biologics.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Duchenne's muscular dystrophy.
Not a fit: Patients with other forms of muscular dystrophy or unrelated neuromuscular disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a novel treatment option for patients suffering from Duchenne's muscular dystrophy.
How similar studies have performed: Other research has shown promise in developing antibody treatments for muscular dystrophies, indicating potential success for this approach.
Where this research is happening
Columbus, United States
- Battelle Centers/pub Hlth Res & Evaluatn — Columbus, United States (Active)
Researchers
- Principal investigator: Burnaugh, Amanda — Battelle Centers/pub Hlth Res & Evaluatn
- Study coordinator: Burnaugh, Amanda
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.